What it is
GLOW is a research-market product: one vial of lyophilised powder containing three peptides that are also sold separately, GHK-Cu, BPC-157 and TB-500. It is marketed for skin, hair and tissue repair, with the "glow" name pointing at the skin angle.
The usual vial is sold as 70 mg total. Most listings split that as 50 mg GHK-Cu, 10 mg BPC-157 and 10 mg TB-500, but the ratio is a supplier decision rather than a standard, so read the label of the vial you actually hold. GHK-Cu is the dominant component by weight.
The name has also been used loosely for a do-it-yourself routine that pairs GHK-Cu with topical expression-line peptides such as argireline or SNAP-8. This page is about the pre-mixed three-peptide vial.
The three components
GHK-Cu. A naturally occurring three-amino-acid peptide that binds copper, first identified in human plasma in 1973. In cell and animal studies it increases collagen and other skin-matrix proteins and speeds wound healing in rats and rabbits. Human data is limited to small 8 to 12 week topical cosmetic studies; there are no published human injection trials. Its inclusion is what gives GLOW its skin positioning. Full detail: GHK-Cu (injectable) and GHK-Cu (topical).
BPC-157. A 15-amino-acid synthetic peptide based on a sequence from a protein in human gastric juice. It is the most-discussed repair peptide on the research market, with a large body of rodent studies on tendon, ligament, muscle and gut healing and very little controlled human data. Full detail: BPC-157.
TB-500. A synthetic peptide based on the active region of thymosin beta-4, a naturally occurring protein involved in cell migration and the actin cytoskeleton. Research interest centres on wound and tissue repair, again mostly in animals. Full detail: TB-500.
The logic of the blend is that the three are thought to act through different routes: GHK-Cu on collagen and matrix remodelling, BPC-157 on blood vessel growth and soft-tissue repair, TB-500 on cell migration. That is a rationale, not a finding.
What the research found
On the blend. Nothing. No study, animal or human, has tested GHK-Cu, BPC-157 and TB-500 together in one injection. Any claim that the combination works better than its parts, or is "synergistic", is untested.
On the components. The evidence summarised above belongs to each peptide alone, mostly in cells and rodents, and mostly with local application or different doses and routes from those used in the blend. Human evidence exists only for topical GHK-Cu.
Mixing also creates questions no one has answered: whether the three peptides stay stable together once reconstituted, and whether copper from GHK-Cu interacts with the other two in solution.
Side effects and safety concerns
There is no controlled human safety data for the blend or for injected use of any of its three components. All three were on the US FDA's list of bulk substances for compounding that may present significant safety risks. For GHK-Cu the agency cited possible immunogenicity from aggregation and impurities in injectable products; for BPC-157 and the thymosin beta-4 fragment it cited possible immunogenicity for some routes, and for BPC-157 a lack of information on whether it would cause harm in humans. Those entries were withdrawn in April 2026 after the nominations were withdrawn, which does not make any of them approved or permitted compounding ingredients.
A blend also removes flexibility. Because the ratio is fixed, you cannot adjust or stop one component without the others, and if a reaction occurs there is no way to tell which peptide caused it.
GLOW vs KLOW vs single peptides
| Product | Contents | Studied as a combination? |
|---|---|---|
| GLOW | GHK-Cu + BPC-157 + TB-500 | No |
| KLOW | GLOW plus KPV | No |
| Wolverine stack | BPC-157 + TB-500 | No |
| Single vials | One peptide each | Individual cell and animal data |
Status in the Philippines
None of the three components is registered with FDA Philippines as a medicine, and none is a controlled substance under RA 9165. GLOW is sold by several local research-peptide suppliers. For reconstitution arithmetic, the reconstitution calculator works on total vial weight; remember each dose then carries all three peptides in the fixed ratio.
Local stock GLOW blend 70mg at Primara Labs, delivered in Metro Manila and nationwide. Research use only.
Storage
Keep lyophilised powder refrigerated and away from light. Once reconstituted with bacteriostatic water, store at 2 to 8°C. Blends have no published stability data, so this is a case where using the vial sooner rather than later is sensible. In a brownout, a cooler with ice packs beats a warming fridge. See the beginner guide for handling basics.
